High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease
Diagnosis of tuberculosis is sometimes difficult because of the low specificity of diagnostic procedures especially in patients on end-stage renal disease (ESRD). As abnormal vitamin D metabolism has been reported in tuberculosis, the aim of the present study was to determine whether serum concentra...
Saved in:
Published in | Clinical nephrology Vol. 62; no. 3; p. 202 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.09.2004
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Diagnosis of tuberculosis is sometimes difficult because of the low specificity of diagnostic procedures especially in patients on end-stage renal disease (ESRD). As abnormal vitamin D metabolism has been reported in tuberculosis, the aim of the present study was to determine whether serum concentration of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) may be a useful diagnostic indicator of tuberculosis in patients with ESRD.
Serum concentrations of 1,25-(OH)2D3, parathyroid hormone (PTH), and calcium were compared in 6 patients with ESRD and active tuberculosis (ESRD-TB group) and 110 patients with ESRD and no tuberculosis (ESRD group). These parameters were compared before and after treatment for tuberculosis in patients of ESRD-TB group.
Hypercalcemia was observed in all 6 patients in the ESRD-TB group. Both higher serum concentration of 1,25-(OH)2D3 and lower serum concentration of PTH were observed in the ESRD-TB group relative to the ESRD group, suggesting enhanced extrarenal production of 1,25-(OH)2D3 and suppressed secretion of PTH by hypercalcemia in the ESRD-TB group. However, these parameters could not be used to distinguish the ESRD-TB group from the ESRD group. The ratio of 1,25-(OH)2D3 to PTH in serum was above 0.9 in the ESRD-TB group and below 0.9 in the ESRD group. Antituberculous treatment reduced this ratio to the range observed in the ESRD group.
High ratio of 1,25-(OH)2D3 to PTH in serum is noted in active tuberculous patients with ESRD because of enhanced extrarenal production of 1,25-(OH)2D3. |
---|---|
AbstractList | Diagnosis of tuberculosis is sometimes difficult because of the low specificity of diagnostic procedures especially in patients on end-stage renal disease (ESRD). As abnormal vitamin D metabolism has been reported in tuberculosis, the aim of the present study was to determine whether serum concentration of 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) may be a useful diagnostic indicator of tuberculosis in patients with ESRD.
Serum concentrations of 1,25-(OH)2D3, parathyroid hormone (PTH), and calcium were compared in 6 patients with ESRD and active tuberculosis (ESRD-TB group) and 110 patients with ESRD and no tuberculosis (ESRD group). These parameters were compared before and after treatment for tuberculosis in patients of ESRD-TB group.
Hypercalcemia was observed in all 6 patients in the ESRD-TB group. Both higher serum concentration of 1,25-(OH)2D3 and lower serum concentration of PTH were observed in the ESRD-TB group relative to the ESRD group, suggesting enhanced extrarenal production of 1,25-(OH)2D3 and suppressed secretion of PTH by hypercalcemia in the ESRD-TB group. However, these parameters could not be used to distinguish the ESRD-TB group from the ESRD group. The ratio of 1,25-(OH)2D3 to PTH in serum was above 0.9 in the ESRD-TB group and below 0.9 in the ESRD group. Antituberculous treatment reduced this ratio to the range observed in the ESRD group.
High ratio of 1,25-(OH)2D3 to PTH in serum is noted in active tuberculous patients with ESRD because of enhanced extrarenal production of 1,25-(OH)2D3. |
Author | Fujigaki, Y Yonemura, K Matsushima, H Ohtake, T Hishida, A |
Author_xml | – sequence: 1 givenname: K surname: Yonemura fullname: Yonemura, K email: katsuh@hama-med.ac.jp organization: Hemodialysis Unit, Hamamatsu University School of Medicine, Hamamatsu, Japan. katsuh@hama-med.ac.jp – sequence: 2 givenname: T surname: Ohtake fullname: Ohtake, T – sequence: 3 givenname: H surname: Matsushima fullname: Matsushima, H – sequence: 4 givenname: Y surname: Fujigaki fullname: Fujigaki, Y – sequence: 5 givenname: A surname: Hishida fullname: Hishida, A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15481852$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kM1OwzAQhH0ooj8g8QTID0DAv0k4okIpUiUucK7seNMYNXZkO0DEy2MEnEba-XZHO0s0c94BQheUXEtBxU3jhpIxwmZoQTihBRGczNEyxjdCGKl5fYrmVIqa1pIt0NfWHjocVLIe-xbTKyYLY7vJBP85vdukeuvwPcfJ40FlrJuCtwZ3PvQ5FmczQhj7n900agjNePRjzGyy4FLEHzZ1GJwpYlIHwAGcOmJjI6gIZ-ikVccI53-6Qq-bh5f1ttg9Pz6t73ZFw5hIRV2VXGkutBYUFAfdVCUTUknW0jypmCqrqiFEl0K05a00PNtVfjbTjRY1W6HL37vDqHsw-yHYXoVp_98C-wbb2V6L |
CitedBy_id | crossref_primary_10_4009_jsdt_54_183 crossref_primary_10_1128_microbiolspec_TNMI7_0035_2016 crossref_primary_10_4009_jsdt_49_343 crossref_primary_10_1179_1973947815Y_0000000043 crossref_primary_10_1016_j_jsbmb_2015_12_003 crossref_primary_10_1038_ajh_2010_124 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.5414/cnp62202 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 15481852 |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 29B 36B 3O- 3V. 53G 5GY 5RE 6J9 7X7 88E 8FI 8FJ AAQQT ABOCM ABUWG ACGFO ACGFS ADBBV AENEX AFFNX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CGR CUY CVF EBS ECM EIF EJD EMB EMOBN F5P FD6 FYUFA HMCUK J5H M1P MJL N4W NPM P2P PQQKQ PROAC PSQYO SV3 UKHRP VDS X7M XBR XDU ZGI ZXP ~4P |
ID | FETCH-LOGICAL-c224t-8763ab34bb41ea3ebc76245a52f141e72a677c00b644f695d362470021eacb482 |
ISSN | 0301-0430 |
IngestDate | Sat Sep 28 08:40:12 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c224t-8763ab34bb41ea3ebc76245a52f141e72a677c00b644f695d362470021eacb482 |
PMID | 15481852 |
ParticipantIDs | pubmed_primary_15481852 |
PublicationCentury | 2000 |
PublicationDate | 2004-Sep |
PublicationDateYYYYMMDD | 2004-09-01 |
PublicationDate_xml | – month: 09 year: 2004 text: 2004-Sep |
PublicationDecade | 2000 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Clinical nephrology |
PublicationTitleAlternate | Clin Nephrol |
PublicationYear | 2004 |
SSID | ssj0020838 |
Score | 1.775427 |
Snippet | Diagnosis of tuberculosis is sometimes difficult because of the low specificity of diagnostic procedures especially in patients on end-stage renal disease... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 202 |
SubjectTerms | Aged Aged, 80 and over Biomarkers - blood Calcitriol - blood Calcium - blood Female Humans Hypercalcemia - blood Kidney Failure, Chronic - complications Male Parathyroid Hormone - blood Tuberculosis - blood Tuberculosis - diagnosis |
Title | High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15481852 |
Volume | 62 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWc9NJL0aBr2gQ89OaqlUhKso5BFgQFkl5iwDkFJCVFKirJcKQCaX8gn50ZklJlN0WXi2CQtkzrPZNvhjNDQt5priTjGixVHSSeYDL3EpWGnu9LGcSKJ8EM853PzqPTufi0CBeTyd0oaqlr1Qf9_cG8kv9BFdoAV8yS_Qdkh5tCA7wGfOEKCMP1rzDGII2pgRA1H8xJhyz00rK4TTE45RuY_VVZT484CkxT47u4XTVlOi1AqDa2XAiMs6tMoECnspXuvmJIrCu26jLfsjr1QENe4wEr9caeTl_joM-vrDMgx5qn_hK-qOpWcs2l-rlopY0KGmK0z2R7090UZSXXUiZOui_ltbRna1-uuSjEEIM1pGahz0K4DRg37UZsRC8-nkNNCvYvczueVw6A6HoZsY23ACrLymCMBhimg_-5d6PKdt-1RbbiGc6U5-j1cYY7yNSZ3Y2yP8MWMcYBfeyHY453srfYMFCMULl4Sp44C4MeWLrskElWPyM_kCrUUIU2OQ3eP0AUesRp29ARUagjCoVOQxT87IgotCcKRaLQgSjUEIU6ojwn85Pji8NTz5274WkQdC0ukFwqLpQSQSZ5pjSsmCKUIcsDaImZjOJY-74CLZ1HSZiCCBIxqkVYxZWYsRdku4bBvSJUKrC3E8ZiP5Ii8lOFecwaVKPSPFZCvCYv7bO6WtriKlf9U9z9bc8b8vgnyd6SRzn8m7M9kIat2je43QMJwGUS |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+ratio+of+1%2C25-dihydroxyvitamin+D3+to+parathyroid+hormone+in+serum+of+tuberculous+patients+with+end-stage+renal+disease&rft.jtitle=Clinical+nephrology&rft.au=Yonemura%2C+K&rft.au=Ohtake%2C+T&rft.au=Matsushima%2C+H&rft.au=Fujigaki%2C+Y&rft.date=2004-09-01&rft.issn=0301-0430&rft.volume=62&rft.issue=3&rft.spage=202&rft_id=info:doi/10.5414%2Fcnp62202&rft_id=info%3Apmid%2F15481852&rft_id=info%3Apmid%2F15481852&rft.externalDocID=15481852 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0301-0430&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0301-0430&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0301-0430&client=summon |